InvestSMART

Artrya Limited (ASX: AYA) - Announcements

Current share price for AYA : $5.680 0.27 (4.99%)+

ASX company news and announcements for Artrya Limited (AYA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Artrya Limited (AYA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Artrya Limited (AYA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Artrya Limited (AYA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$926 Results of Annual General Meeting 13 Nov 2025 3:29PM $3.760 $5.680 risen by 51.06%
$926 Artrya AGM Chair Address and Company Presentation 13 Nov 2025 11:40AM $3.740 $5.680 risen by 51.87%
$926 SAPPHIRE Study Expands With Inclusion of Ascension 13 Nov 2025 9:29AM $3.600 $5.680 risen by 57.78%
$926 Annual General Meeting Link 10 Nov 2025 3:48PM $3.685 $5.680 risen by 54.14%
$926 Application for quotation of securities - AYA 7 Nov 2025 6:41PM $3.380 $5.680 risen by 68.05%
$926 Issue of Shares on Exercise of Performance Rights 7 Nov 2025 6:38PM $3.380 $5.680 risen by 68.05%
$926 Mass General Brigham to Participate in SAPPHIRE Study 5 Nov 2025 9:38AM $3.410 $5.680 risen by 66.57%
$926 Becoming a substantial holder from WAM/WAA/WMI/WAX 4 Nov 2025 7:05PM $3.410 $5.680 risen by 66.57%
$926 Becoming a substantial holder 4 Nov 2025 5:13PM $3.410 $5.680 risen by 66.57%
$926 Application for quotation of securities - AYA 31 Oct 2025 9:42AM $3.260 $5.680 risen by 74.23%
$926 Completion of Placement and Cleansing Notice 31 Oct 2025 9:36AM $3.260 $5.680 risen by 74.23%
$926 Quarterly Activities/Appendix 4C Cash Flow Report 27 Oct 2025 9:29AM $3.830 $5.680 risen by 48.30%
$926 Results of General Meeing 24 Oct 2025 3:29PM $3.830 $5.680 risen by 48.30%
$926 Application for quotation of securities - AYA 23 Oct 2025 5:42PM $3.650 $5.680 risen by 55.62%
$926 Issue of Shares on Exercise of Performance Rights 23 Oct 2025 5:41PM $3.650 $5.680 risen by 55.62%
$926 Corporate Governance Statement and Appendix 4G 13 Oct 2025 6:59PM $2.850 $5.680 risen by 99.30%
$926 Annual Report to shareholders 13 Oct 2025 6:57PM $2.850 $5.680 risen by 99.30%
$926 Notice of Annual General Meeting/Proxy Form 13 Oct 2025 6:54PM $2.850 $5.680 risen by 99.30%
$926 Application for quotation of securities - AYA 10 Oct 2025 5:44PM $2.750 $5.680 risen by 106.55%
$926 Issue of Shares on Exercise of Performance Rights 10 Oct 2025 5:42PM $2.750 $5.680 risen by 106.55%
$926 SCF Update - Successful Q-Submission Meeting with FDA 10 Oct 2025 9:54AM $2.650 $5.680 risen by 114.34%
$926 Huntsville Hospital Heart Centre Confirmed in SAPPHIRE Study 7 Oct 2025 8:18AM $2.400 $5.680 risen by 136.67%
$926 Change in substantial holding 6 Oct 2025 4:40PM $2.400 $5.680 risen by 136.67%
$926 Application for quotation of securities - AYA 3 Oct 2025 4:54PM $2.400 $5.680 risen by 136.67%
$926 Issue of Shares on Exercise of Performance Rights 3 Oct 2025 4:51PM $2.400 $5.680 risen by 136.67%

51 - 75 of 502 results

Page 3 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.